Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients
Phase 4
Completed
- Conditions
- End-stage Renal Disease
- Interventions
- Drug: placebo comparator
- First Posted Date
- 2008-09-03
- Last Posted Date
- 2021-10-08
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 160
- Registration Number
- NCT00745225
- Locations
- 🇭🇰
Queen Mary Hospital, Tung Wah Hospital, Hong Kong, Hong Kong
Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients
Not Applicable
Completed
- Conditions
- Endstage Renal DiseaseDiabetes
- Interventions
- Drug: Placebo comparator
- First Posted Date
- 2008-09-03
- Last Posted Date
- 2017-01-10
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 22
- Registration Number
- NCT00745914
- Locations
- 🇭🇰
Queen Mary Hospital and Tung Wah Hospital, Hong Kong, Hong Kong
🇭🇰Queen Mary Hospital, Tung Wah Hospital, Hong Kong, Hong Kong
Parathyroidectomy in Endstage Renal Disease
Not Applicable
Completed
- Conditions
- Endstage Renal Disease
- Interventions
- Procedure: parathyroidectomy
- First Posted Date
- 2008-09-03
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 122
- Registration Number
- NCT00745719
- Locations
- 🇭🇰
Queen Mary Hospital, Tung Wah Hospital, Hong Kong, Hong Kong
Sevelamer Hydrochloride in Peritoneal Dialysis Patients
- First Posted Date
- 2008-09-03
- Last Posted Date
- 2020-06-18
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 60
- Registration Number
- NCT00745589
- Locations
- 🇭🇰
Queen Mary Hospital, Tung Wah Hospital, Hong Kong, Hong Kong
Safety and Pharmacokinetics Study of Oral Lithium in Patients With Chronic Spinal Cord Injury
Phase 1
Completed
- Conditions
- Spinal Cord Injuries
- First Posted Date
- 2007-02-05
- Last Posted Date
- 2012-01-16
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 20
- Registration Number
- NCT00431171
- Locations
- 🇨🇳
MacLehose Medical Rehabilitation Centre, Pokfulam, Hong Kong SAR, China
Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2010-07-28
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 42
- Registration Number
- NCT00363831
- Locations
- 🇭🇰
Sanofi-aventis, Hong Kong, Hong Kong
Randomized Control Trial of Using Tongue Acupuncture in Autistic Spectrum Disorder Using PET Scan for Clinical Correlation
Phase 3
Completed
- Conditions
- Autistic DisorderAutism
- First Posted Date
- 2006-07-21
- Last Posted Date
- 2006-10-20
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 30
- Registration Number
- NCT00355329
- Locations
- 🇭🇰
Duchess of Kent of Children Hospital, Hong Kong, Hong Kong
Randomized Controlled Trial of Acupuncture Versus Sham Acupuncture in Autistic Spectrum Disorder
Phase 3
Completed
- Conditions
- Autistic DisorderAutism
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2006-07-14
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 50
- Registration Number
- NCT00352248
- Locations
- 🇭🇰
Duchess of Kent of Children Hospital, Hong Kong, Hong Kong
Use of Acupuncture In Children With Autistic Spectrum Disorder
Phase 3
Completed
- Conditions
- AutismAutistic Disorder
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2006-07-14
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 30
- Registration Number
- NCT00352352
- Locations
- 🇭🇰
Duchess of Kent of Children Hospital, Hong Kong, Hong Kong
Use of Acupuncture In Children With Autistic Spectrum Disorder
Phase 3
Completed
- Conditions
- Autistic DisorderAutism
- First Posted Date
- 2006-06-30
- Last Posted Date
- 2008-09-03
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 80
- Registration Number
- NCT00346736
- Locations
- 🇭🇰
TWGHs Tung Wah Hospital, Hong Kong, Hong Kong